The over 200 people who descended on the Computer History Museum in the heart of Silicon Valley last week for the second annual Techonomy Bio event learned we were heading toward growing meat, cell phones, and houses. They learned as well that we are in a renaissance of progress in human health. But they also heard thoughts on why we have more allergies and worries about how the public thinks about science. The daylong program ranged from stem cells and bio-architecture to venture capital and public opinion about science, but the common thread was the intersection of progress in the dual realms of life science and information technology. As speakers noted throughout the day, the intersection of big data and biology has helped create a field ripe for breakthroughs. More
Tag Index / Showing 1 - 7 of 7 results for “Drew Endy”
Bio & Life Sciences Techonomy Events
Meat Without Animals and Sequencing the Planet at Techonomy Bio
Bio & Life Sciences Techonomy Events
Predicting a Future Where Products Are Parented
Waving his smartphone at the audience, Stanford bioengineer Drew Endy said, “I’m trying to grow one of these.” Let the day of mindblowing conversations about the future of biology begin. Endy joined Google Director of Engineering David Glazer, Silicon Valley venture capitalist Steve Jurvetson, and Merck Director of Scientific Modeling Platforms Chris Waller for the TE Bio 15 opening panel, “You Say You Want a Revolution.” Techonomy CEO David Kirkpatrick moderated the discussion about how innovations at the intersection of IT and biology will transform industries and products beyond life sciences. More
Techonomy Bio 2015 Live Webcast
Techonomy Bio is a big-picture exploration of the transformative global social and economic benefits driven by the rapid advances being made in the biological and life sciences. Powered by IT developments and spurred on by new collaborative and open-source thinking, these advances affect everything from manufacturing to medicine, food to fuel and business to buildings. We […] More
Next Week’s Techonomy Bio: A Focus on Systems of Life
At last year's Techonomy Bio, we put venture capitalist Steve Jurvetson on a panel of investors. In his enthusiasm for the unbridled potential of innovation in the life sciences to transform society, Jurvetson at one point said "we're sitting on a can of miracles." Why a can? He did not say, but his observation became a kind of touchstone for us at Techonomy for why we continue to build this event. "Sitting on a Can of Miracles" is what we're calling this year's session on investing in bio-progress. Jurvetson himself we have promoted to our opening panel, which our Director of Programs Alex Cudaback christened "You Say You Want a Revolution?" Here we ask where we'll see the most impact from life sciences innovation, and how information technology is driving bio-progress. More
Bio & Life Sciences Techonomy Events
Talking About Biology’s Grass Roots Revolution
“As a reporter who’s covered both biotech and what the rest of the world calls just plain ‘tech,’ I can tell you those stories about biology can be tougher to tell,” said WIRED senior writer Marcus Wohlsen during a session, entitled "The Next Revolution Will Be Biologized," that he moderated at Techonomy 2014 in Half Moon Bay last week. Wholsen shared the stage with a panel of the sector’s thought leaders: attorney and consultant Nancy Kelley; chemical biologist Floyd Romesberg of The Scripps Research Institute; synthetic biology pioneer Drew Endy of Stanford University; and Brian Frezza, founder of “biotech lab for hire” Emerald Therapeutics. More
Synthetic Biology’s Future Assembled in Boston Last Weekend
iGEM challenges multidisciplinary student teams to solve real-world problems with entirely new biological systems that they design and build from interchangeable sequences of DNA. The assembly last Monday marked the final segment of the 2014 International Genetically Engineered Machines (iGEM) competition, and the culmination of a weekend of intense bonding, as well as dancing and drinking, among the world’s most brilliant young bioengineers. More
Bio & Life Sciences Techonomy Events
What We Learned at Techonomy Bio
Techonomy's offices on Manhattan's West 22d Street have been buzzing ever since our half-day Techonomy Bio conference on June 17. We got an overwhelmingly positive reception for a meeting that brought leading researchers and experts in the life sciences together with IT and Internet thinkers and business generalists. Drew Endy, a Stanford professor who is one of the world's leaders in synthetic biology, on stage called the event "awesome" and said he had never seen such a collection of people in one place. "People in other sectors of technology simply don’t know very much about biology and biology’s economic impact," he said. More
Newsletter